Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573293
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional AthletesCairo UniversityCompletedNot Applicable
NCT07573293Completed
Not Applicable
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional Athlet...Cairo University
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573176
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderJanssen Research & Development, LLCNot Yet RecruitingPhase 3
NCT07573176Not Yet Recruiting
Phase 3
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Ma...Janssen Research & Develo...
NCT07574242
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 UniversityCompletedNot Applicable
NCT07574242Completed
Not Applicable
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 University
NCT07574034
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction SyndromeGregor AndelfingerNot Yet RecruitingNot Applicable
NCT07574034Not Yet Recruiting
Not Applicable
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction...Gregor Andelfinger
NCT07572461
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based ChemotherapySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot Yet RecruitingNot Applicable
NCT07572461Not Yet Recruiting
Not Applicable
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Pe...Second Affiliated Hospita...
NCT07572409
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory StudymanxiaxiaRecruitingNot Applicable
NCT07572409Recruiting
Not Applicable
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Singl...manxiaxia
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLCNot Yet RecruitingPhase 1
NCT07572006Not Yet Recruiting
Phase 1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Develo...
NCT07573969
Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caudal Analgesia for Lumbosacral SurgeriesAin Shams UniversityRecruitingPhase 3
NCT07573969Recruiting
Phase 3
Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caud...Ain Shams University
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573254
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With Mechanical Low Back PainIstinye UniversityCompletedNot Applicable
NCT07573254Completed
Not Applicable
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational...Istinye University
NCT07574112
Muscle Energy Technique With And Without Myofascial Release in Patients With Cervicogenic HeadacheUniversity of LahoreCompletedNot Applicable
NCT07574112Completed
Not Applicable
Muscle Energy Technique With And Without Myofascial Release in Patients With Cer...University of Lahore
NCT07572747
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesKhalid F AlhabibNot Yet RecruitingPhase 3
NCT07572747Not Yet Recruiting
Phase 3
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countrie...Khalid F Alhabib
NCT07573787
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste DisordersChristoph GrimmTerminatedNot Applicable
NCT07573787Terminated
Not Applicable
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste Dis...Christoph Grimm
Result Breakdown
Not yet recruiting11 (55%)
Completed4 (20%)
Recruiting4 (20%)
Terminated1 (5%)
not_applicable12 (60%)
Phase 33 (15%)
Phase 22 (10%)
Phase 41 (5%)
Not Specified1 (5%)
Phase 11 (5%)